|Articles|September 20, 2022
Cognizant's Shared Investigator Platform Grows to More Than a Quarter Million Users Globally
SIP SaaS solution has surpassed 250,000 users across 100 countries worldwide.
Advertisement
Cognizant announced that its Shared Investigator Platform (SIP), a life sciences Software as a Service (SaaS) solution that streamlines clinical trials, has surpassed 250,000 users across 100 countries worldwide. This digital platform facilitates research and collaboration by allowing clinical study documents and safety notifications to be exchanged across site and sponsor teams.
Read more about the platform
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Clinical Trials in 2026: Platformization, AI Fluency, and the Redrawing of the Value Chain
2
Breaking Out of AI Pilot Mode in Clinical Development
3
ACT Brief: Community Sites Compete on Readiness, COA Licensing Bottlenecks Slow Start-Up, and AI’s Foundations in Pharmacovigilance
4
ACT Brief: Community Sites Prove Readiness, Platformization Reshapes Clinical Ops, and AI Targets Precision Care at JPM
5